Elastrin Therapeutics
PrivateLast Round
Debt
Sep 12, 2024
Total Funding Raised
$17.58M
Company Overview
Elastrin Therapeutics is a biotechnology company that develops nanoparticle-based therapies to reverse cardiovascular calcification and restore tissue elasticity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elastrin Therapeutics Comparables
Compare Elastrin Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Revel Pharmaceuticals | 76% | |
| NanoPhoria Bioscience | 75% | |
| Cyclarity Therapeutics | 74% | |
Elastrin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 12, 2024 | ||||
| Series A | Nov 3, 2023 | ||||
| Convertible Debt | Sep 8, 2023 | ||||
| Seed | Apr 7, 2022 | ||||
| Pre Seed | Mar 1, 2021 |
Elastrin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kizoo Technology Capital | Seed |
| Starbloom Capital | Seed |
| SC Launch | Seed |
| SCRA | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2024
$500K debt round completed.
- Nov 3, 2023
Raised $4.75M in Series A funding.
Elastrin Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elastrin Therapeutics's valuation, stock price, and market status.